Stock Updates

Morning Top Movers: Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) | Healthcare

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) falls under the large cap category with a market cap of 28.5 B. The following data highlights Alexion Pharmaceuticals, Inc. (ALXN) for Monday July 17, 2017 showing the earning date of 7/27/2017 8:30:00 AM.

Overview

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), a Biotechnology company from Healthcare sector has been doing very well. The company has reported a price of $126.71 today, marking a change of -0.16%.

Alexion Pharmaceuticals, Inc. has a current return on equity (ROE) of *TBA while its debt to equity stands at 0.34. The return on investment (ROI) is at 4.20% and the gross margin is reported to be 91.80%.

Alexion Pharmaceuticals, Inc. is predicting a healthy earnings per share growth of 14.00% over the period of next five years.

Performance Analysis

The stats for Alexion Pharmaceuticals, Inc.’s performance is below.

The weekly performance stands at 2.97%, while the monthly performance measure stands at 7.38%. Not surprisingly its volatility is at 3.18% with an average volume of 3183.02. Volatility is a statistical measure of the dispersion of returns for a given security. It can be measured by using the variance between returns from the market index. Generally speaking, there is always a positive correlation between high volatility and high risk.

The performance per month is at 7.38%, while the performance per quarter stands at .

Ratio

has a float short of 2.54% at present and the short ratio is at 1.78. Shares shorted can actually exceed 50% of the float in a company. Because the float is the amount of a company’s shares that are publicly owned, all tradable shares can therefore be borrowed by short sellers.

Valuation

The numbers in regards to Alexion Pharmaceuticals, Inc.’s valuation are below.

The market cap is at 28.5 B, while the P/E stands at 60.17, with a P/S of 8.76 and earnings per share this year of 162.90%.

The earnings per share is used as a primary indicator of a company’s profitability or loss. Earnings per share is basically the portion of a company’s profit that is allocated to each outstanding share of common stock.

Candle Graph for (NASDAQ: ALXN)

ALXN

Alexion Pharmaceuticals, Inc. NASDAQ : ALXN | Healthcare | Biotechnology

Disclaimer: The views, opinions, and information expressed in this article are those of the authors and will not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts.. Examples of analysis performed within this article are for demonstration purposes only. They should not be utilized to make stock portfolio or financial decisions as they are based on limited and open source information only. Hence the assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.

About the author

Peter Clarke